This trial is testing whether reducing dead space with a pulmonary vasodilator (inhaled nitric oxide) can improve symptoms of breathlessness during exercise in patients with mild COPD.
2 Primary · 5 Secondary · Reporting Duration: At 4 minutes from start of exercise
20 Total Participants · 2 Treatment Groups
Primary Treatment: Nitric Oxide · Has Placebo Group · Phase < 1
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: